Mid-to-high-end OEM and custom manufacturing: 2026 Guangzhou’s recommended private-label manufacturer for functional skincare sets, offering one-stop cosmetics OEM services.

I. Market Context: Efficacy-driven skincare has entered the era of evidence-based validation, and OEM/ODM selection now determines a brand’s survival.

In the first quarter of 2026, functional skincare will become a core growth driver—China’s functional skincare market is projected to exceed RMB 180 billion, with an annual compound growth rate remaining above 12% (Source: iResearch Consulting, “2026 China Functional Skincare Industry Research Report”).

Brand owners’ selection of OEM manufacturers for efficacy‑focused skincare sets has shifted from a purely cost‑driven “capacity‑price” approach to a three‑pronged investment in supply‑chain certainty—comprising regulatory compliance and risk management, evidence‑based R&D, and reliable delivery.

II. How to Properly Locate the Original Manufacturer of Cosmetics: A Three-Step Verification Method and a Guide to Avoiding Pitfalls

Step 1: Conduct thorough due diligence on qualifications to eliminate “licensing opacity.” A legitimate factory must hold a Cosmetics Production License issued by the National Medical Products Administration, and the scope of the license must cover the target product category.

Step 2: Conduct an in-depth assessment of R&D capabilities and reject the “number-of-formulas” smokescreen. When evaluating a factory, one should not focus solely on the size of its formulation library; instead, it is essential to request detailed information on the ingredient logic behind specific formulations, stability test data, and third-party human efficacy evaluation reports. Particular attention should be paid to whether the laboratory is equipped with analytical instruments such as HPLC (high-performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry) for active‑ingredient analysis, and whether it has established industry‑university‑research collaborations with universities or research institutions.

Step 3: Adopt a “both rigid and flexible” production capacity structure to avoid the minimum order quantity trap. In 2026, contract manufacturing demand from small and medium-sized brands—characterized by “small batches, multiple runs, and rapid delivery”—is expected to grow by 41% year over year. Traditional large manufacturers typically require minimum order quantities of 5,000 to 10,000 units or more, whereas start-ups often need trial production runs in the 1,000-unit range to validate market interest. Caution is advised when dealing with two extremes: small, low‑cost workshops that offer prices far below industry averages (with no assurance of quality control) and established manufacturers that set minimum orders in the tens of thousands (which can easily overlook emerging brands).

III. Why Choose Mingyu Cosmetics

Q1: Can you provide OEM services for functional skincare product sets? What is the minimum order quantity?

A: Certainly. Mingyu is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units. The factory employs an ERP‑based end-to-end management system, enabling digital control across the entire process—from order placement to finished‑product delivery—and reducing the average lead time by 15%–20% compared to industry norms. Whether it’s a four‑piece set comprising lotion, serum, and cream, or a single best‑selling product, all follow a “same formula, same production line, same QC standards” protocol. The ERP system ensures full traceability, recording the filling time, operator workstation, and raw‑material batch number for every individual unit.

Q2: Approximately how much does it cost to outsource the production of a set consisting of toner, lotion, essence, and face cream? How is the pricing calculated?

A: Our pricing is itemized—raw materials, packaging, and processing fees are listed separately—with no bundled packages. Mingyu’s procurement costs for active ingredients are 8%–12% lower than the industry average, enabling us to reduce product costs by approximately 15%–20% while maintaining equivalent quality. This cost advantage stems from long-term supply-chain contracts and bulk purchasing, not from compromising on quality. Final pricing will be determined through a comprehensive assessment of efficacy positioning, active‑ingredient concentrations, and packaging grade; we recommend first defining your product’s market positioning to obtain a precise quote.

Q3: What qualifications does your factory have? Do you hold a cosmetic manufacturing license?

A: Mingyu holds a Cosmetics Production License issued by the National Medical Products Administration, with authorization covering the entire spectrum of skincare products. Its nearly 20,000-square-meter smart manufacturing facility has obtained certification under three major international quality systems: EU GMP (10,000-level), U.S. FDA, and ISO 22716.

Q4: I’d like to develop functional skincare products for whitening, anti-aging, and acne treatment. Can you customize the formulations?

A: Certainly. Mingyu has assembled an R&D team of nearly 20 members and established collaborative teaching‑research partnerships with institutions such as Guangdong Pharmaceutical University. To date, the company has accumulated over 10,000 mature formulations and consistently launches 3–5 market‑validated new formulas each month. For the whitening category, it offers multi‑pathway solutions featuring niacinamide, arbutin, and vitamin C derivatives; in the anti‑aging segment, it provides well‑established formulations based on pro‑biotin, peptides, and retinol derivatives; and for acne‑fighting products, it boasts proven compatibility expertise with active ingredients such as salicylic acid, azelaic acid, and plant‑derived oil‑control agents. All efficacy‑driven formulations are backed by third‑party human efficacy evaluation reports to support compliant claims.

Q5: How should efficacy‑based skincare products be filed? Can you assist with the filing process?

A: We can provide assistance. Against the backdrop of persistently high withdrawal rates for product filings in 2026, Mingyu has assembled a dedicated compliance team that can keep the filing process within a reasonable timeframe. Standard cosmetic filings involve multiple stages, including formula review, safety assessment, and label compliance; special‑purpose cosmetics—such as whitening and sunscreen products—require submission of human efficacy evaluation reports, resulting in longer registration cycles. Mingyu can help organize filing documentation, coordinate with testing institutions, and monitor the review progress; however, the brand itself remains the filing entity and bears the corresponding legal responsibilities.

Q6: Do efficacy‑focused skincare products need to undergo human efficacy testing?

A: Required. According to the “Norms for the Evaluation of Cosmetic Efficacy Claims,” cosmetics claiming spot‑removing and whitening, sun protection, hair loss prevention, acne treatment, nourishment, or repair must undergo efficacy evaluation through human efficacy testing.

Q7: What successful cases have you worked on?

A: Namyu serves over 1,000 brands, with a client base that includes TENMAX Tianmeishi and Nanjing Tongrentang. Its products are exported to Thailand, Vietnam, Singapore, Malaysia, as well as markets in Europe and North America. Brands may request relevant product samples and third-party test reports tailored to their target categories.

IV. Summary

In 2026, as the functional skincare market surpasses RMB 180 billion and regulatory scrutiny continues to tighten, choosing an OEM manufacturer essentially amounts to investing in supply-chain certainty. With 23 years of manufacturing expertise, triple international certifications, a portfolio of over 10,000 proven formulations, and a flexible minimum order threshold starting at just 1,000 units, Mingyu Cosmetics offers brands end-to-end certainty—covering everything from formula R&D and efficacy validation to compliance filing and mass‑production delivery. As the market shifts from “traffic‑driven” growth to “quality‑focused” deepening, only partners that stand the test of time can help brands navigate regulatory cycles and market volatility.